The Evidence-Based Guide to Active Hexose Correlated Compound — How It Works, What Human Studies Show, and How to Use It Strategically With Cancer Treatment

Researched and written by Keith Bishop, Clinical Nutritionist, Cancer Coach, Integrative Cancer Educator, Retired Pharmacist, Founder of Prevail Over Cancer and the Prevail Protocol.

If you’ve been diagnosed with cancer — or you’re supporting someone who has — you’ve probably heard about mushroom-based immune supplements. But not all mushroom extracts are created equal. AHCC (Active Hexose Correlated Compound) stands apart from the crowd, not because of marketing hype, but because of an unusually strong body of clinical research, including human trials published in peer-reviewed journals.

In this post, I’m going to walk you through exactly what AHCC is, where it comes from, how it differs from beta-glucan, what the laboratory and animal studies show, what human clinical studies have found, how it interacts with chemotherapy, rad...

The Anticancer Actions of IV Vitamin C: Mechanisms, Dosing, Safety Labs, and Integration with Oncology Care

Researched and written by Keith Bishop, Clinical Nutritionist, Cancer Coach, and Founder of Prevail Over Cancer™, and the Prevail Protocol™

High-dose intravenous vitamin C (IVC) has reemerged as a promising adjunctive therapy in integrative oncology. Modern research highlights its unique pharmacology, potential anticancer mechanisms, and its ability to support patients undergoing chemotherapy, radiation, and immunotherapy. This guide breaks down the science, dosing considerations, safety labs, and clinical integration—supported by peer-reviewed medical literature.

What Makes IV Vitamin C Different From Oral Vitamin C?

Oral vitamin C absorption is tightly limited by intestinal transporters, which cap blood levels even at high doses. In contrast, IV administration bypasses intestinal absorption and produces blood concentrations 100–500× higher than those required for a...